(Q36125227)

12 August 2017

New regimens to prevent tuberculosis in adults with HIV infection (English)

1 reference

12 August 2017

0 references

Lawrence H Moulton

3

0 references

Richard E Chaisson

series ordinal

9

object named as

Richard E Chaisson

1 reference

12 August 2017

8

Glenda E Gray

1 reference

12 August 2017

1

Neil A Martinson

1 reference

12 August 2017

4

Reginah Msandiwa

1 reference

12 August 2017

6

Malathi Ram

1 reference

12 August 2017

Grace L Barnes

2

1 reference

12 August 2017

Harry Hausler

series ordinal

5

1 reference

12 August 2017

James A McIntyre

series ordinal

7

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 July 2011

1 reference

12 August 2017

10

1 reference

The New England Journal of Medicine

inferred from page(s)

published in

1 reference

12 August 2017

365

1 reference

12 August 2017

1

1 reference

12 August 2017

11-20

1 reference

6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407678

Tuberculosis during the first year of antiretroviral therapy in a South African cohort using an intensive pretreatment screening strategy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407678

Treatment of latent tuberculosis infection in HIV infected persons

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407678

Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407678

Isoniazid preventive therapy and risk for resistant tuberculosis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407678

Combining PMTCT with active case finding for tuberculosis.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407678

Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407678

Value of chest radiography in a tuberculosis prevention programme for HIV-infected people, Botswana

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407678

Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407678

Long-term effect of preventive therapy for tuberculosis in a cohort of HIV-infected Zambian adults

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407678

Analysis of rifapentine for preventive therapy in the Cornell mouse model of latent tuberculosis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407678

Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407678

A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407678

Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407678

Twice weekly tuberculosis preventive therapy in HIV infection in Zambia

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407678

Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407678

Yield of acid-fast smear and mycobacterial culture for tuberculosis diagnosis in people with human immunodeficiency virus

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407678

Completion of isoniazid preventive therapy among HIV-infected patients in Tanzania

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407678

Outcomes of nevirapine- and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapy

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407678

Consecutive-dose pharmacokinetics of rifapentine in patients diagnosed with pulmonary tuberculosis.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407678

Pharmacokinetics of rifapentine at 600, 900, and 1,200 mg during once-weekly tuberculosis therapy

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407678

Preventive therapy against tuberculosis in people living with HIV

23 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21732833

12 December 2020

inferred from PubMed ID database lookup

Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21732833

12 December 2020

inferred from PubMed ID database lookup

Single and multiple dose pharmacokinetics of rifapentine in man: part II

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21732833

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1056/NEJMOA1005136

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

21732833

1 reference